J Eller

611 total citations
7 papers, 465 citations indexed

About

J Eller is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, J Eller has authored 7 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in J Eller's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (3 papers) and Respiratory and Cough-Related Research (3 papers). J Eller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (3 papers) and Respiratory and Cough-Related Research (3 papers). J Eller collaborates with scholars based in Germany, United Kingdom and Canada. J Eller's co-authors include H. Lode, Tom Schaberg, Harald Mauch, Michael S. Niederman, L W Poulter, José Roberto Lapa e Silva, T. Schaberg, Jürg Hamacher, Peter Cole and K. Börner and has published in prestigious journals such as Annals of the New York Academy of Sciences, CHEST Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J Eller

7 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Eller Germany	6	340	205	86	84	80	7	465
C. Andrew DeAbate United States	9	183 0.5×	244 1.2×	32 0.4×	46 0.5×	112 1.4×	12	380
Cristina Espinosa Spain	6	315 0.9×	169 0.8×	85 1.0×	73 0.9×	14 0.2×	7	427
Tammy Abuan United States	9	325 1.0×	150 0.7×	25 0.3×	63 0.8×	42 0.5×	9	460
Guillermo Rodriguez-Gomez United States	8	135 0.4×	120 0.6×	10 0.1×	145 1.7×	118 1.5×	11	388
Paul Jordens Belgium	7	256 0.8×	84 0.4×	47 0.5×	296 3.5×	12 0.1×	7	430
M. Ioanas Spain	8	200 0.6×	203 1.0×	30 0.3×	24 0.3×	12 0.1×	12	376
Stephen A. Farkas United States	7	87 0.3×	222 1.1×	11 0.1×	12 0.1×	94 1.2×	8	349
M. Badia Spain	8	48 0.1×	81 0.4×	14 0.2×	32 0.4×	62 0.8×	14	362
Holly Keyt United States	8	178 0.5×	52 0.3×	48 0.6×	32 0.4×	14 0.2×	13	274
Seung-Kwan Lim South Korea	11	63 0.2×	184 0.9×	12 0.1×	30 0.4×	37 0.5×	18	333

Countries citing papers authored by J Eller

Since Specialization

Citations

This map shows the geographic impact of J Eller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Eller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Eller more than expected).

Fields of papers citing papers by J Eller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Eller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Eller. The network helps show where J Eller may publish in the future.

Co-authorship network of co-authors of J Eller

This figure shows the co-authorship network connecting the top 25 collaborators of J Eller. A scholar is included among the top collaborators of J Eller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Eller. J Eller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lode, H., et al.. (2004). Levofloxacinversusclarithromycin in COPD exacerbation: focus on exacerbation-free interval. European Respiratory Journal. 24(6). 947–953. 45 indexed citations

2.

Wardlaw, Andrew J., et al.. (2004). Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Annals of Allergy Asthma & Immunology. 93(1). 49–55. 26 indexed citations

3.

Lode, H., J Eller, M. Raffenberg, & H. Mauch. (2000). Role of long-acting cephalosporins in the treatment of lower respiratory tract infections. Clinical Microbiology and Infection. 6. 87–89. 1 indexed citations

4.

Eller, J, et al.. (1998). Infective Exacerbations of Chronic Bronchitis. CHEST Journal. 113(6). 1542–1548. 277 indexed citations

5.

Hamacher, Jürg, J Eller, K. Börner, et al.. (1996). Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Antimicrobial Agents and Chemotherapy. 40(1). 105–109. 61 indexed citations

6.

Lode, H., Jürg Hamacher, J Eller, & T. Schaberg. (1995). Changing role of carbapenems in the treatment of lower respiratory tract infections.. PubMed. 96. 17–23. 7 indexed citations

7.

Eller, J, José Roberto Lapa e Silva, L W Poulter, H. Lode, & Peter Cole. (1994). Cells and Cytokines in Chronic Bronchial Infection. Annals of the New York Academy of Sciences. 725(1). 331–345. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact